Bizarre Neuroendocrine Tumour Presentations Abstract #1530

Introduction: Herein we present two cases of neuroendocrine tumours (NET)with atypical presentations.
Aim(s): .
Materials and methods: Case 1:A 87 year-old woman with a growing hypervascular cutaneous lesion in the left scapula was evaluated by Dermatology. The lesion was excised, and histopathology showed a NET metastasis. The patient had no carcinoid syndrome. An abdominal CT scan showed a nodular lesion in the proximal small intestine with exuberant desmoplastic reaction. Somatostatin receptor scintigraphy confirmed overexpression in this lesion and no evidence of distant metastasis. The patient underwent palliative surgery. The surgical specimen confirmed a low-grade (G1) NET (Ki67 1%).
Conference: 13th Annual ENETS conference (2016)
Category: Clinical cases/reports
Presenting Author: Carolina Palmela

To read results and conclusion, please login ...

Further abstracts you may be interested in

#2017 Data on Healthcare Resource Utilization (HCRU) and Treatment Modalities in Patients (Pts) with Advanced (adv), Well-Differentiated (WD) Neuroendocrine Tumors (NETs) of Gastrointestinal (GI) or Lung Origin in Finland
Introduction: The majority of all NETs develop in the GI tract and about one third develop in the lungs; approximately 43% and 51% of pts, respectively, are diagnosed with adv disease (regional or distant metastasis). While GI and lung NETs are rare, their incidence has increased markedly over the past four decades. The severe and progressive nature of adv NET suggests significant costs for pts and payers.
Conference: 15th Annual ENETS conference (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: Lotte Gaasvik
Keywords: NET, HCRU, GI, Lung
#116 Transarterial chemoembolization (TACE) of liver metastasis from pancreatic well-differentiated endocrine carcinoma
Introduction: The behavior of liver metastasis from endocrine pancreatic carcinoma is eterogeneous, and several treatments have been proposed, but no single option is ideal.
Conference: 7th Annual ENETS Conference (2010)
Category: Basic
Presenting Author: MD Vanessa Capitanio
Authors: Capitanio V, Papa M, Zerbi A, Vitali G, ...
#1139 Role of Enteroclysis MDTC in the Diagnosis and Follow-Up of Ileal Neuroendocrine Tumors
Introduction: Among all the well differentiated neuroendocrine tumors (NET) those originating from ileum present the more relevant diagnostic difficulties and remain therefore occult in a relevant percentage of cases in all the stages
Conference: 12th Annual ENETS Conference (2015)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: MD Daniele Maiettini
#1741 Complete Remission of Hepatic Metastasis after Total Gastrectomy for a Gastric Carcinoid Tumor Type 1: A Case Report
Introduction: A 58-year-old woman was referred to our hospital for hepatic lesions and thickening of the walls of the stomach detected by abdominal CT scan. An upper GI endoscopy showed a lesion of the body of the stomach and the histopathologic exam documented a well differentiated NET. 68Ga-DOTATOC PET showed pathologic uptake in the stomach and in the liver (3 lesions). Circulating chromogranin A and gastrin were 596 ng/ml and 2283 pg/ml respectively
Conference: 14th Annual ENETS conference (2017)
Category: Clinical cases/reports
Presenting Author: Valeria Smiroldo
#25 Predictors of response to radio-embolization (TheraSphere ®) treatment of neuro-endocrine liver metastasis
Introduction: Neuroendocrine tumors (NET) frequently metastasize to the liver. Most patients have diffuse, and therefore incurable, disease. NET liver metastasis has been shown to respond to yttrium-90 microspheres therapy. This study aims to define factors that predict response to radio-embolization in patients with NET liver metastases.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr. Mazen Hassanain